Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference30 articles.
1. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship;Mendel;Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,2003
2. A small molecule-kinase interaction map for clinical kinase inhibitors;Fabian;Nat. Biotechnol.,2005
3. Sunitinib efficacy against advanced renal cell carcinoma;Motzer;J. Urol.,2007
4. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors;Adams;Clin. Ther.,2007
5. FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors;Blumenthal;Oncologist,2012
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献